Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company, 6563 [2018-03082]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 31 / Wednesday, February 14, 2018 / Notices
Wireless Telecommunications Bureau
and Wireline Competition Bureau (the
Bureaus) may implement, and (3) certify
its challenge. The USAC system will
validate a challenger’s evidence using
an automated challenge validation
process. Once all valid challenges have
been identified, a challenged party that
chooses to respond to any valid
challenge(s) may submit additional data
via the online USAC portal during the
established response window. A
challenged party may submit technical
information that is probative regarding
the validity of a challenger’s speed tests,
including speed test data and other
device-specific data collected from
transmitter monitoring software or,
alternatively, may submit its own speed
test data that conforms to the same
standards and requirements specified by
the Commission and the Bureaus for
challengers.
In conjunction with the qualified 4G
LTE data separately collected pursuant
to OMB 3060–1242 that will be used to
create the map of areas presumptively
eligible for MF–II support, the
information collected under this MF–II
challenge process collection will enable
the Commission to efficiently resolve
disputes concerning the eligibility or
ineligibility of an area initially deemed
ineligible for MF–II support and
establish the final map of areas eligible
for such support, thereby furthering the
Commission’s goal of targeting MF–II
support to areas that lack adequate
mobile voice and broadband coverage
absent subsidies through a transparent
process.
The Commission received approval
from OMB for the information collection
requirements contained in OMB 3060–
1251 on February 7, 2018.
Federal Communications Commission.
Marlene H. Dortch,
Secretary, Office of the Secretary.
[FR Doc. 2018–03000 Filed 2–13–18; 8:45 am]
BILLING CODE 6712–01–P
[FR Doc. 2018–03166 Filed 2–12–18; 4:15 pm]
Sunshine Act Meeting
Thursday, February 15,
2018 at 10:00 a.m.
TIME AND DATE:
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than March
7, 2018.
A. Federal Reserve Bank of Atlanta
(Kathryn Haney, Director of
Applications) 1000 Peachtree Street NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. Brandt J. Dufrene, Sr., individually
and as trustee for The FSC Trust No. 1,
and Brandt J. Dufrene, Jr., individually
and as the trustee for The FSC Trust No.
2 and the Brandt J. Dufrene, Jr. Trust
No. 1, all of Metairie, Louisiana; to
retain voting shares of First St. Charles
Bancshares, Inc., and thereby indirectly
retain First National Bank USA, both
Boutte, Louisiana.
[FR Doc. 2018–03082 Filed 2–13–18; 8:45 am]
BILLING CODE P
Centers for Disease Control and
Prevention, HHS.
ACTION: Notice of draft document
available for public comment.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability for public
comment on the drugs proposed for
placement on the NIOSH List of
Antineoplastic and Other Hazardous
Drugs in Healthcare Settings, 2018
(List), as well as the NIOSH Policy and
Procedures for Developing the NIOSH
List of Antineoplastic and Other
Hazardous Drugs in Healthcare Settings.
DATES: Comments must be received by
April 16, 2018.
ADDRESSES: Comments may be
submitted, identified by docket numbers
CDC–2018–0004 and NIOSH–233–B, by
either of the following two methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 1090
Tusculum Avenue, Cincinnati, OH
45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and the docket
numbers (CDC–2018–0004; NIOSH–
233–B). All relevant comments received
will be posted without change to
www.regulations.gov, including any
personal information provided.
FOR FURTHER INFORMATION CONTACT:
Barbara MacKenzie, NIOSH, Robert A.
Taft Laboratories, 1090 Tusculum
Avenue, MS–C26, Cincinnati, OH
45226, telephone (513) 533–8132 (not a
toll free number), Email:
hazardousdrugs@cdc.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Interested parties are invited to
participate in this action by submitting
written views, opinions,
recommendation, and/or data.
Comments are invited on any topic
related to the drugs identified in this
notice, including those evaluated for
This Meeting, open to the
public, has been cancelled.
STATUS:
CONTACT PERSON FOR MORE INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
Jkt 244001
NIOSH List of Antineoplastic and Other
Hazardous Drugs in Healthcare
Settings: Proposed Additions to the
NIOSH Hazardous Drug List 2018
I. Public Participation
999 E Street NW, Washington,
DC (Ninth Floor).
22:07 Feb 13, 2018
Centers for Disease Control and
Prevention
[CDC–2018–0004; NIOSH–233–B]
PLACE:
VerDate Sep<11>2014
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6715–01–P
Board of Governors of the Federal Reserve
System, February 9, 2018.
Ann E. Misback,
Secretary of the Board.
FEDERAL ELECTION COMMISSION
daltland on DSKBBV9HB2PROD with NOTICES
Signed:
Dayna C. Brown,
Secretary and Clerk of the Commission.
6563
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 83, Number 31 (Wednesday, February 14, 2018)]
[Notices]
[Page 6563]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03082]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices; Acquisitions of Shares of a Bank
or Bank Holding Company
The notificants listed below have applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and Sec. 225.41 of the Board's
Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank
holding company. The factors that are considered in acting on the
notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
The notices are available for immediate inspection at the Federal
Reserve Bank indicated. The notices also will be available for
inspection at the offices of the Board of Governors. Interested persons
may express their views in writing to the Reserve Bank indicated for
that notice or to the offices of the Board of Governors. Comments must
be received not later than March 7, 2018.
A. Federal Reserve Bank of Atlanta (Kathryn Haney, Director of
Applications) 1000 Peachtree Street NE, Atlanta, Georgia 30309.
Comments can also be sent electronically to
[email protected]:
1. Brandt J. Dufrene, Sr., individually and as trustee for The FSC
Trust No. 1, and Brandt J. Dufrene, Jr., individually and as the
trustee for The FSC Trust No. 2 and the Brandt J. Dufrene, Jr. Trust
No. 1, all of Metairie, Louisiana; to retain voting shares of First St.
Charles Bancshares, Inc., and thereby indirectly retain First National
Bank USA, both Boutte, Louisiana.
Board of Governors of the Federal Reserve System, February 9,
2018.
Ann E. Misback,
Secretary of the Board.
[FR Doc. 2018-03082 Filed 2-13-18; 8:45 am]
BILLING CODE P
